TABLE 2

Clinical Profile of Study Patients with Other Forms of DPLD

Patient no.SmokerTLC*FEV1TLCOUIPTreatedComorbiditySUVmax
1X675927NNRheumatoid5.4
2X1027955NNNone2.2
3X739164NYSjögren2.5
4X768253NNAsbestosis2.1
5X625747NNCrohn2.5
6X969578NNAsbestosis1.9
7X6810049NNNone3.4
8N554333NYNone2
9X557544NYAsbestosis3.1
10X487872NY§Rheumatoid3.1
11X487261YYRheumatoid3.1
12N14NNNone2.7
13X76NNRheumatoid3.3
14Y10645YYRheumatoid3.3
15X7283NNNone3.4
16X698154NNCardiac2.9
17Y38NNNone1.9
18Y867196NNCardiac2.4
  • * PFTs are percentage predicted.

  • 5 mg of prednisolone.

  • 15 mg of prednisolone.

  • § Azathioprine.

  • Methotrexate.

  • Anti-TNF.

  • X = ex-smoker; N = no; Y = yes; TLC = total lung capacity.